{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:40:33Z","timestamp":1759333233408},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[1985]]},"DOI":"10.1007\/bf00541333","type":"journal-article","created":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T16:59:09Z","timestamp":1100797149000},"page":"133-139","source":"Crossref","is-referenced-by-count":11,"title":["Quantitative absorption of interleukin-2 by peripheral blood and synovial fluid lymphocytes from patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"5","author":[{"given":"C.","family":"Knobloch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schlesier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Dr\ufffdger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"G\ufffdrtner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. H.","family":"Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.4049\/jimmunol.117.4.1320","volume":"117","author":"V Paetkau","year":"1976","unstructured":"Paetkau V, Mills G, Gerhart S, Monticone V (1976) Proliferation of murine thymic lymphocytes in vitro is mediated by the concanavalin A-induced release of a lymphokine (costimulator). J Immunol 117:1320?1324","journal-title":"J Immunol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1084\/jem.148.6.1523","volume":"148","author":"H Wagner","year":"1978","unstructured":"Wagner H, R\u00f6llinghoff M (1978) T-T cell interactions during in vitro cytotoxic allograft response. I. Soluble products from Ly1 + T cells trigger autonomously antigen primed Ly23+ T cells to cell proliferation and cytotoxic activity. J Exp Med 148:1523?1538","journal-title":"J Exp Med"},{"key":"CR3","unstructured":"Wagner H, R\u00f6llinghoff M, Kurrle R, Seiler FR (eds) (1980) ?Interleukin-2?. Behring Inst Mitt 67"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.154.5.1455","volume":"154","author":"RJ Robb","year":"1984","unstructured":"Robb RJ, Munck A, Smith KA (1984) T cell growth factor receptors ? quantitation, specificity, and biological relevance. J Exp Med 154:1455?1474","journal-title":"J Exp Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-065X.1982.tb00412.x","volume":"63","author":"R Palacios","year":"1982","unstructured":"Palacios R (1982) Mechanism of T cell activation: role and functional relationship of HLA-DR antigens and interleukins. Immunol Rev 63:73?110","journal-title":"Immunol Rev"},{"key":"CR6","first-page":"245","volume":"67","author":"BM Stadler","year":"1980","unstructured":"Stadler BM, Farrar JJ, Oppenheim JJ (1980) Cell cycle dependent productions of human interleukin-2. Behring Inst Mitt 67:245?248","journal-title":"Behring Inst Mitt"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.130.6.2651","volume":"130","author":"M Linker-Israeli","year":"1983","unstructured":"Linker-Israeli M, Bakke AC, Kitridou RC, Gendler S, Gillis S, Horwitz DA (1983) Defective production of IL-1 and IL-2 in patients with SLE. J Immunol 130:2651?2655","journal-title":"J Immunol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.4049\/jimmunol.128.2.679","volume":"128","author":"M Lopez-Botet","year":"1983","unstructured":"Lopez-Botet M, Fontan G, Rodriguez MCG, De Landazuri MO (1983) Relationship between IL-2 synthesis and the proliferative response to PHA in different primary immunodeficiencies. J Immunol 128:679?683","journal-title":"J Immunol"},{"key":"CR9","first-page":"677","volume-title":"Interleukins, lymphokines and cytokines","author":"HH Peter","year":"1983","unstructured":"Peter HH, Gronewold P, Kirchner H, Northoff H (1983) Lymphokine productions in common varied immunodeficiency, polyclonal hypergammaglobulinemia, and granulomatous diseases. In: Oppenheim JJ, Cohen S (eds) Interleukins, lymphokines and cytokines. Academic Press, London, pp 677?685"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.4049\/jimmunol.123.6.2704","volume":"123","author":"GD Bonnard","year":"1979","unstructured":"Bonnard GD, Yasaka K, Jacobson D (1979) Ligand-activated T cell growth factor-induced proliferation: Absorption of T cell growth factor by activated T cell. J Immunol 123:2704?2708","journal-title":"J Immunol"},{"key":"CR11","first-page":"67","volume":"72","author":"M R\u00f6llinghoff","year":"1983","unstructured":"R\u00f6llinghoff M, Scheurich P, Hardt C, Pfizenmaier K (1983) Analysis of interleukin-2 receptor sites on activated T cells. Behring Inst Mitt 72:67?72","journal-title":"Behring Inst Mitt"},{"key":"CR12","first-page":"175","volume":"9","author":"MW Ropez","year":"1958","unstructured":"Ropez MW, Bennett GA, Cobb S, Jacox R, Jessar R (1958) 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9:175?176","journal-title":"Bull Rheum Dis"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.4049\/jimmunol.126.4.1398","volume":"126","author":"T Uchiyama","year":"1981","unstructured":"Uchiyama T, Nelson DL, Fleischer TA, Waldman TA (1981) A monoclonal antibody (anti-TAC) reactive with activated and functionally mature human T cells. II. Expressions of TAC antigen on activated cytotoxic killer T cells, suppressor cells and on one of two types of helper T cells. J Immunol 126:1398?1403","journal-title":"J Immunol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4049\/jimmunol.131.2.690","volume":"131","author":"JM Depper","year":"1983","unstructured":"Depper JM, Leonhard WJ, Robb RJ, Waldman TA, Greene WC (1983) Blockade of the interleukin-2 receptor by anti-TAC antibody: inhibition of human lymphocyte activation. J Immunol 131:690?696","journal-title":"J Immunol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.4049\/jimmunol.120.6.2027","volume":"120","author":"S Gillis","year":"1978","unstructured":"Gillis S, Ferm MM, Ou W, Smith KA (1978) Parameters of production and a quantitative microassay for activity. J Immunol 120:2027?2032","journal-title":"J Immunol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-065X.1980.tb00327.x","volume":"51","author":"KA Smith","year":"1980","unstructured":"Smith KA (1980) T cell growth factor. Immunol Rev 51:337?356","journal-title":"Immunol Rev"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.1982.tb00414.x","volume":"63","author":"J Farrar","year":"1982","unstructured":"Farrar J, Benjamin WR, Hilfiker ML, Howard M, Farrar WL, Fuller-Farrar J (1982) The biochemistry, biology, and role of interleukin-2 in the induction of cytotoxic T cell and antibody forming B cell responses. Immunol Rev 63:129?166","journal-title":"Immunol Rev"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1084\/jem.156.2.454","volume":"156","author":"K Welte","year":"1982","unstructured":"Welte K, Wang CY, Mertelsmann R, Venuta S, Feldman SP, Moore MAS (1982) Purification of human interleukin-2 to apparent homogeneity and its molecular heterogeneity. J Exp Med 156:454?464","journal-title":"J Exp Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/eji.1830121117","volume":"12","author":"PF M\u00fchlradt","year":"1982","unstructured":"M\u00fchlradt PF, Opitz HG (1982) Clearance of interleukin-2 from the blood of normal and t cell depleted mice. Eur J Immunol 12:983?985","journal-title":"Eur J Immunol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.4049\/jimmunol.130.5.2203","volume":"130","author":"JH Donohue","year":"1983","unstructured":"Donohue JH, Rosenberg SA (1983) The fate of interleukin-2 after in vivo administration. J Immunol 130:2203?2208","journal-title":"J Immunol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.4049\/jimmunol.130.6.2644","volume":"130","author":"N Flomenberg","year":"1983","unstructured":"Flomenberg N, Welte K, Mertelsmann R, Kernan N, Ciobanu N, Venuta S, Feldman S, Kruger G, Kirkpatrick D, Dupont B, O'Reilly R (1983) Immunologic effects of interleukin-2 in primary immunodeficiency diseases. J Immunol 130:2644?2650","journal-title":"J Immunol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0171-2985(84)80077-7","volume":"167","author":"R Dopfer","year":"1984","unstructured":"Dopfer R, Niethammer D, Peter HH, Kniep EM, Monner DA, M\u00fchlradt PF (1984) In vivo effects of interleukin-2 on lymphocyte subpopulations in a patient with a combined immunodeficiency. Immunobiology 167:452?461","journal-title":"Immunobiology"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4049\/jimmunol.131.2.731","volume":"131","author":"A Yachie","year":"1983","unstructured":"Yachie A, Miyawaki T, Uwadana N, Ohzeki S, Tanigushi N (1983) Sequential expression of T cell activation (TAC) antigen and Ia determinants on circulating human T cells after immunization with tetanus toxoid. J Immunol 131:731?735","journal-title":"J Immunol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/art.1780241106","volume":"24","author":"GR Burmester","year":"1981","unstructured":"Burmester GR, Yu DTY, Irani AM, Kunkel HG, Winchester RJ (1981) Ia+ T cells in synovial fluid and tissue of patients with rheumatoid arthritis. Arthritis Rheum 24:1370?1376","journal-title":"Arthritis Rheum"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4049\/jimmunol.128.1.351","volume":"128","author":"RI Fox","year":"1982","unstructured":"Fox RI, Fong S, Sabharwal N, Carstens SA, Kung PC, Vaughan J (1982) Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis. J Immunol 128:351?354","journal-title":"J Immunol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00541249","volume":"2","author":"M Duclos","year":"1982","unstructured":"Duclos M, Zeidler H, Liman W, Pichler WJ, Rieber P, Peter HH (1982) Characterization of blood and synovial fluid lymphocytes from patients with rheumatoid arthritis and other joint diseases by monoclonal antibodies (OKT series) and acid alpha-naphthyl esterase staining. Rheumatol Int 2:75?82","journal-title":"Rheumatol Int"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.4049\/jimmunol.133.3.1230","volume":"133","author":"GR Burmester","year":"1984","unstructured":"Burmester GR, Jahn B, Gramatzki M, Zacher J, Kalden JR (1984) Activated T cells in vivo and in vitro: Divergence in expression of TAC and Ia antigens in the nonblastoid small T cells of inflammation and normal T cells activated in vitro. J Immunol 133:1230?1234","journal-title":"J Immunol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1084\/jem.160.4.1126","volume":"160","author":"RJ Robb","year":"1984","unstructured":"Robb RJ, Green WC, Rusk CM (1984) Low and high affinity receptors for interleukin 2. J Exp Med 160:1126?1146","journal-title":"J Exp Med"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02715703","volume":"3","author":"M Schlesier","year":"1984","unstructured":"Schlesier M, Ramb CH, Peter HH (1984) Characterization of cloned T lymphocytes from blood and synovial fluid of a patient with rheumatoid arthritis. Clin Rheumatol 3:87 (Abstr)","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00541333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00541333\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00541333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T09:51:22Z","timestamp":1682848282000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00541333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985]]}},"alternative-id":["BF00541333"],"URL":"https:\/\/doi.org\/10.1007\/bf00541333","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985]]}}}